BoCom
China EV battery solutions provider raises $229m
Sunwoda Electric Vehicle Battery (EVB), a subsidiary of lithium-ion battery maker Sunwoda Electronic, has raised a CNY 1.65bn (USD 229m) Series B round from domestic investors.
Baidu-backed autonomous truck developer raises $67m
DeepWay, an intelligent driving solutions provider for trucks established by Baidu, has raised a Series A round of CNY 460m (USD 67m) led by Qiming Venture Partners.
PE-backed Gogox sinks on debut after $98m Hong Kong IPO
Gogox, a last-mile logistics company formed through the merger of Hong Kong's GoGoVan and an affiliate of mainland China-based 58.com, fell 22% on its Hong Kong trading debut following a HKD 771.4 (USD 98.3m) IPO.
China GPU chip designer secures $313m Series A
Moore Threads, a Chinese chip designer established 13 months ago by a team from Nvidia, has closed Series A at RMB2 billion ($313 million) led by Shanghai Guosheng Capital, 5Y Capital, and a BOC International fund.
China's Deepexi raises $100m Series B
Deepexi, a Chinese start-up that provides digital transformation solutions to enterprise customers, has raised $100 million in a Series B funding round led by Guotai Junan Securities and an investment arm of China Industrial International Trust Asset...
Hong Kong last-mile delivery player Gogox raises $100m
Gogox, a Hong Kong-headquartered last-mile logistics company formerly known as GoGoVan, has raised $100 million in funding led by the international arm of China Bank of Communications and Cyberport Macro Fund.
Chinese cloud player Qiniu gets $141m Series F
Chinese enterprise cloud service provider Qiniu Cloud has raised RMB1 billion ($141 million) in Series F funding from the state-owned China Structural Reform Fund, Bocom International, and Hongzhao Fund.
Chinese drug developer Mabworks raises $159m Series C
Beijing Mabworks Biotech has raised a RMB1.13 billion ($159 million) Series C round led by CICC Capital, Lyzz Capital, CITIC Securities Investment, and Huge Capital.
Chinese antibody drug developer raises $150m
Akeso Biopharma, a Chinese biotech company specializing in antibody drugs, has raised a $150 million Series D round led by Loyal Valley Capital and Sino Biopharm.
KKR-backed Tianrui raises $124m in Hong Kong IPO
China Tianrui Group Cement, a portfolio company of private equity giant KKR, has raised HK$966.2 million ($124 million) through an IPO on the Hong Kong Stock Exchange.
AgBank launches $2.3b private equity fund in Wuxi
Agricultural Bank of China and the Wuxi city government have launched a RMB15 billion ($2.3 billion) private equity fund. The AgBank (Wuxi) Private Equity Fund will receive an initial capital injection of RMB5 billion ($773 million).